NEW YORK, Nov 1 - When Affymetrix entered the uncharted waters of DNA chips in 1991, microarrays were highly specialized and complex tools that few companies were ready to market or use.

But over the past few years, many companies have begun to understand the underlying technology and find ways to circumvent Affy’s host of over 300 protective patents, pointing to the possibility that these tools could become commodity items.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.